Rare diseases
Investigational molecules
Locations
Back to Spain1 657 clinical trials in Sevilla, Spain across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on Ravulizumab for Adults with Immunoglobulin A Nephropathy (IgAN) to Preserve Kidney Function
SpainStudy of Pembrolizumab and Olaparib for Patients with Advanced Colorectal Cancer with DNA Repair Deficiency
SpainStudy on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis
SpainStudy on the Safety and Tolerability of Teprotumumab for Patients with Thyroid Eye Disease
SpainStudy Comparing Pirtobrutinib with Idelalisib and Rituximab or Bendamustine and Rituximab for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
SpainStudy of inavolisib, palbociclib and fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer
SpainStudy on the Long-term Safety and Effectiveness of Danicopan with Ravulizumab or Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
SpainStudy on Allogenic Stem Cells and Amniotic Membrane for Patients with Advanced Corneal Ulcers Unresponsive to Standard Treatment
SpainStudy of Lurbinectedin Alone or with Irinotecan for Patients with Relapsed Small Cell Lung Cancer
SpainStudy on Inclisiran and Rosuvastatin for Lowering Cholesterol in Patients with High Cholesterol Levels
SpainLong-term safety study of apraglutide (weekly injections) in patients with Short Bowel Syndrome
SpainStudy on the Effectiveness and Safety of 7 vs. 14 Days of Antibiotic Treatment with Meropenem for Patients with Pseudomonas Aeruginosa Blood Infection
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Type 1 Diabetes management and weight-related conditions, evaluating new therapeutic approaches for glycemic control and metabolic health.
Studies aim to improve treatment outcomes for patients with complex metabolic conditions.
Advanced clinical trials examining treatments for Multiple Sclerosis and neurodegenerative disorders, including pioneering research in Frontotemporal Dementia and Parkinson's disease.
Research focuses on developing targeted treatments for various neurological conditions.
Comprehensive vaccine development programs targeting Influenza, Cytomegalovirus, and meningococcal infections, with emphasis on preventive medicine.
Studies aim to enhance vaccine efficacy and immune response across different age groups.
Groundbreaking studies in cancer treatment, including research on bladder cancer and mantle cell lymphoma, exploring combination therapies and targeted treatments.
Focus on developing innovative approaches to improve cancer treatment outcomes.
Clinical investigations into Psoriatic Arthritis and inflammatory conditions, evaluating novel therapeutic approaches and treatment combinations.
Research aims to develop more effective treatments for chronic autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
